Zymeworks Inc.
ZYME · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $65 | $0 | $0 | $0 |
| + Debt | $19 | $0 | $0 | $0 |
| Enterprise Value | -$45 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -43.3% | 79.7% | -12.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -56.8% | 5.3% | -82.3% | -59.8% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -71% | 4.8% | -83.5% | -75.8% |
| EPS Diluted | -0.26 | 0.03 | -0.3 | -0.31 |
| % Growth | -966.7% | 110% | 3.2% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |